Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
579 studies found for:    Open Studies | "Bacterial Infections"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients
Condition: Gram Negative Bacterial Infections
Intervention: Drug: colistin
22 Recruiting An Open-Label Study of the Pharmacokinetics of a Single Dose of Telavancin in Pediatric Subjects Aged 1 to 17 Years
Condition: Gram-Positive Bacterial Infections
Intervention: Drug: Telavancin
23 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
24 Recruiting Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Condition: Gram-Negative Bacterial Infections
Intervention:
25 Recruiting Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)
Conditions: Bacterial Infections;   Wounds
Interventions: Drug: Vancomycin 1.25-1.50% in a complex gel formulation trademarked Vancogel;   Drug: Placebo, complex gel formulation without Vancomycin
26 Recruiting Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department
Conditions: Systemic Inflammatory Response Syndrome;   Fever
Intervention: Biological: Procalcitonin (PCT) as a diagnostic marker of bacterial infection
27 Recruiting Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)
Conditions: Bacterial Infection;   Critically Ill
Intervention: Drug: Tigecycline
28 Recruiting Safety Evaluation of Seraph® to Reduce Bacteremia in Patients on Hemodialysis
Conditions: Bacteremia;   Bacterial Infection
Intervention: Device: Seraph Microbind Affinity Blood Filter
29 Recruiting Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections
Conditions: Community-associated Infections;   Health-care Acquired Infections;   Nosocomial Infections
Intervention: Other: antibiotic treatment of by TREAT/PCR
30 Recruiting Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region
Condition: Tropical Infectious Diseases
Intervention: Other: None, treatment as actual best practice
31 Recruiting Preventing Bacterial and Viral Infections Among Injection Drug Users
Conditions: Bacterial Infection;   HIV
Interventions: Behavioral: SKIN Intervention;   Other: Treatment as Usual
32 Recruiting Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
Conditions: Bacterial Infections;   Skin Structures and Soft Tissue Infections
Interventions: Drug: Omadacycline;   Drug: Linezolid
33 Recruiting Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm From Chronic Lower Extremity or Diabetic Foot Ulcers
Conditions: Lower Extremity or Diabetic Foot Ulcers;   Bacterial Infection
Interventions: Device: Larval Debridement Therapy;   Procedure: Bedside Sharp Debridement
34 Not yet recruiting Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
Conditions: Pulmonary Disease, Chronic Obstructive;   Bacterial Infections
Interventions: Other: Sample collecting;   Other: Lung function measure
35 Recruiting Helicobacter Eradication Aspirin Trial
Conditions: Gastrointestinal Ulcer Haemorrhage;   Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Lansoprazole 30mg, Clarithromycin 500mg, Metronidazole 400mg;   Drug: Placebo lansoprazole 30mg, clarithromycin 500mg, metronidazole 400mg
36 Recruiting Reinfection After Eradication of Helicobacter Pylori Infection
Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori);   Eradication Therapy of Helicobacter Pylori;   Detection of Helicobacter Pylori
Intervention:
37 Recruiting Staph Household Intervention for Eradication (SHINE)
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Staphylococcus Aureus;   MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Chlorhexidine;   Drug: Mupirocin;   Behavioral: Household cleaning
38 Recruiting Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Conditions: Proven or Suspected Gram-negative Bacterial Infection;   Peri-operative Prophylaxis
Interventions: Drug: Ceftolozane/Tazobactam 1.5 g;   Drug: Ceftolozane/Tazobactam 27 mg/kg;   Drug: Ceftolozane/Tazobactam 18 mg/kg
39 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
40 Not yet recruiting A Trial Assessing Efficacy of Various Antimicrobial Techniques for Reducing Bacterial Load
Condition: Disease Due to Gram-positive Bacteria
Interventions: Other: Povidone-Iodine;   Other: Antibiotic topical cream;   Other: Chlorhexidine 1%

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.